PML-RARA, Quantitative near me in Ranchi
The PML-RARA, Quantitative test detects a specific gene fusion between PML and RARA, which is linked to acute promyelocytic leukemia (APL), a type of blood cancer. This test helps doctors confirm APL, monitor treatment, check for remaining leukemia cells, and guide therapy decisions, allowing personalized care for patients. Detection of the PML–RARA fusion is essential for selecting appropriate therapy. Standard treatment includes all-trans retinoic acid (ATRA), often combined with chemotherapy, which specifically targets leukemia cells carrying this fusion. Measuring PML–RARA levels during and after treatment helps assess treatment effectiveness and predict the risk of relapse. This test is widely available with Tata 1mg labs at an affordable price in Ranchi.
YES 
NO 
- Cingam SR, Koshy NV. Acute Promyelocytic Leukemia. [Updated 2023 Jun 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from:
- Liquori A, Ibañez M, Sargas C, Sanz MÁ, Barragán E, Cervera J. Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single PML-RARA Fusion Gene. Cancers (Basel). 2020 Mar 8;12(3):624. [Accessed 22 Oct. 2025]. Available From:
